Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/16811
Title: Oxygen therapy for interstitial lung disease: physicians' perceptions and experiences
Austin Authors: Khor, Yet H ;Goh, Nicole SL;McDonald, Christine F ;Holland, Anne E 
Affiliation: Department of Respiratory and Sleep Medicine, Austin Health, Heidelberg, Victoria, Australia
Institute for Breathing and Sleep, Heidelberg, Victoria, Australia
University of Melbourne, School of Medicine, Melbourne, Victoria, Australia
Alfred Health, Department of Allergy, Immunology and Respiratory Medicine, Melbourne, Victoria, Australia
La Trobe University, Physiotherapy, Melbourne, Victoria, Australia
Alfred Health, Physiotherapy, Melbourne, Victoria, Australia
Issue Date: Dec-2017
metadata.dc.date: 2017-08-10
Publication information: Annals of the American Thoracic Society 2017; 14(12): 1772-1778
Abstract: RATIONALE: Domiciliary oxygen therapy (DOT) is commonly prescribed for patients with interstitial lung disease (ILD) and hypoxaemia, although evidence supporting benefit is limited. OBJECTIVES: The aim of this study was to explore perspectives of respiratory physicians about DOT in patients with ILD. METHODS: A qualitative study was undertaken with 26 respiratory physicians from Australia. Interviews were transcribed verbatim and coded independently by two investigators. Themes were established by consensus. RESULTS: Physicians reported symptomatic relief as the main indication for prescribing DOT in ILD. Concerns were raised regarding the applicability of current clinical guidelines for DOT to ILD. Compared to patients with other lung diseases, there was a lower threshold for DOT prescription for patients with ILD. Physicians perceived patients with ILD complied better with recommended DOT prescription. There was significant variation in infrastructure for oxygen assessment and prescription, patient support and equipment provision amongst institutions and states. Various patients' attitudes and experiences towards DOT were reported, but notable was physicians' perception of significant anxiety in most patients using DOT due to social stigma and concerns that DOT signified end-stage disease. CONCLUSIONS: Oxygen therapy was primarily prescribed for symptomatic management in patients with ILD. Education provision and supports regarding DOT varied significantly.
URI: http://ahro.austin.org.au/austinjspui/handle/1/16811
DOI: 10.1513/AnnalsATS.201705-372OC
ORCID: 0000-0002-5434-9342
0000-0003-2061-845X
0000-0003-2065-4346
0000-0001-6481-3391
PubMed URL: https://pubmed.ncbi.nlm.nih.gov/28796538
Type: Journal Article
Appears in Collections:Journal articles

Show full item record

Page view(s)

6
checked on Dec 1, 2022

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.